INL and UMinho enter agreement with IPLEXMED to advance graphene-based diagnostic platform

A few days ago, the International Iberian Nanotechnology Laboratory (INL) and University of Minho (UMinho) signed a licensing agreement with IPLEXMED, a spin-out company specializing in advanced medical diagnostics. The agreement grants the company rights to commercialize a new graphene-based diagnostic platform.